Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hubertus Buyck
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
European Oncology and Haematology
Oncology
Hematology
Related publications
Thrombopoietin Receptor Agonists for the Treatment of Inherited Thrombocytopenia
Haematologica
Hematology
Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
A United Kingdom Immune Thrombocytopenia (ITP) Forum Review of Practice: Thrombopoietin Receptor Agonists
British Journal of Haematology
Hematology
Eltrombopag: An Update on the Novel, Non-Peptide Thrombopoietin Receptor Agonist for the Treatment of Immune Thrombocytopenia
Annals of Hematology
Medicine
Hematology
Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia
British Journal of Haematology
Hematology
Autologous 111 Indium‐oxinate‐labelled Platelet Sequestration Study in Patients With Immune Thrombocytopenia Treated by Thrombopoietin Receptor‐agonists
British Journal of Haematology
Hematology
Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Deciphering Predictive Factors for Choice of Thrombopoietin Receptor Agonist, Treatment Free Responses, and Thrombotic Events in Immune Thrombocytopenia
Scientific Reports
Multidisciplinary
